Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Symbotic Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2020
FY2022
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
92.1
252
593
1,177
1,788
2,247
Cost of revenue
111
241
494
987
1,543
1,824
Gross profit
-18.9
10.4
99.6
190
246
423
Research and development
55.9
73.4
124
195
173
216
Selling, general and administrative
35.6
59.4
116
218
189
299
General and administrative
6.39
Operating expenses
91.4
133
240
413
362
538
Operating income
-110
-122
-6.49
-140
-223
-117
-115
Other non-operating income
0.81
0.07
0.02
1.29
10.7
37
36.1
Pre-tax income
-110
-122
-139
-213
-79.7
-78.9
Income tax
-0.05
0
0
-4.62
4.21
-1.63
Net income to minority interests
-60.1
-184
-71.2
-74.1
Net income
-110
-122
-6.48
-6.86
-23.9
-13.5
-16.9
EBITDA
-105
-118
-134
-214
-95.9
-75.4
EPS, basic
-0.13
-0.37
-0.14
-0.16
EPS, diluted
-0.13
-0.37
-0.14
-0.16
Shares, basic (weighted)
54.1
64.3
95.7
109
Shares, diluted (weighted)
54.1
64.3
95.7
109
Balance sheet
FY2020
FY2022
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
58.3
157
0.81
353
259
727
1,245
Receivables
63.4
3.41
69.2
202
187
Inventory
33.6
91.9
136
106
164
Other current assets
6.37
0.74
25.7
85.2
101
86.6
Total current assets
260
1.55
605
992
1,356
1,885
Property, plant and equipment
18.6
24.9
34.5
97.1
118
Lease right-of-use assets
5.5
12.4
15.3
23.5
Goodwill
0
59.9
Intangible assets
1.16
0.65
0.22
3.66
79.1
Other non-current assets
0.33
0.34
24.2
41
131
Total assets
281
322
631
1,051
1,579
2,396
Accounts payable
28
0.19
68.4
110
175
287
Accrued liabilities
31.1
3.3
47.3
100
166
Deferred revenue
259
394
787
676
1,242
Total current liabilities
337
4.05
523
1,025
1,017
1,729
Lease liabilities
12.3
16.1
24
Other non-current liabilities
3.99
7.9
28
42
63.6
Total liabilities
558
15.2
562
1,053
1,188
1,918
Paid-in capital
0
0
1,238
1,254
1,524
1,557
Retained earnings
-1,155
-13.5
-1,287
-1,310
-1,324
-1,334
Other comprehensive income
-2.09
-2.29
-1.69
-2.59
-2.7
Shareholders' equity
-13.5
7.18
0.08
197
220
Minority interests
61.8
-2.8
193
258
Total equity
-844
-1,113
-13.5
68.9
-2.72
390
478
Total liabilities and equity
281
322
631
1,051
1,579
2,396
Shares outstanding
554
557
586
591
Cash flow statement
FY2020
FY2022
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-110
-122
-6.48
-139
-208
-84.7
-91
Depreciation and amortization
5.73
4.49
5.99
9.48
20.8
39.6
Stock-based compensation
0.07
0.1
26.9
154
112
184
Deferred income tax
-0.05
0
0
-4.91
3.92
-4.21
Change in receivables
0.34
-1.62
-0.51
-65.8
-132
15.1
Change in inventory
-5.65
-16.8
-60.6
-66.4
0.1
-58.9
Change in payables
-4.81
22.2
0.19
41.5
41.4
65.3
96.9
Cash from operations
-124
110
-3.38
-148
231
-58.1
867
Capital expenditures
-5.07
-12.2
-18
-15.7
-42.2
Acquisitions
0
0
-142
Purchases of investments
0
0
-408
-48.7
0
Sales and maturities of investments
0
0
130
340
0
Cash from investing
-5.06
-12.2
-320
-18
-299
156
-351
Stock issued
0
0
0
258
0
Cash from financing
100
0
324
362
-24.1
371
0.67
Exchange rate effect
-0.68
0.97
0.57
0.23
-0
-0.03
Net change in cash
-30
98.4
0.81
197
-92.5
469
517
Free cash flow
-129
97.4
-166
215
-100
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $43.47 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
21.3%
Gross profit / revenue.
Operating margin
-0.0%
Operating income / revenue.
EBITDA margin
1.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
2.4%
Pre-tax income / revenue.
Net margin
0.3%
Net income / revenue.
Operating cash flow margin
33.8%
Cash from operations / revenue.
Effective tax rate
-0.6%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
1.2%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
0.2%
Net income / average total assets.
R&D / revenue
7.7%
Research and development expense / revenue.
SG&A / revenue
13.3%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
9.0%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
1.2%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
25.7%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
55.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
72.0%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
61.9%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
11.6%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
213.0%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
51.8%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
56.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y
13.6%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
26.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.33x
Current assets / current liabilities.
Quick ratio
0.95x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.81x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.06
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$19.86
Revenue / diluted weighted shares.
Operating cash flow per share
$6.71
Cash from operations / diluted weighted shares.
Book value per share
$1.17
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
3,203x
Market cap / net income. Only when net income is positive.
P/S
9.94x
Market cap / revenue.
P/B
37.1x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
46.5x
Market cap / tangible book value, when positive.
P/OCF
29.4x
Market cap / cash from operations, when positive.
EV/Sales
9.28x
Enterprise value / revenue.
EV/EBITDA
797x
Enterprise value / EBITDA, when both are positive.
Earnings yield
0.0%
Net income / market cap (the inverse of P/E).
What was Symbotic Inc.'s revenue in fiscal 2025?
Symbotic Inc. reported revenue of $2.25B for fiscal 2025, 25.7% higher than the year before.
Was Symbotic Inc. profitable in fiscal 2025?
No. It reported a net loss of $16.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.